Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Manchanda, Rahul
1986.
Criteria for Measuring Change: Statistical Significance vs Clinical Significance.
British Journal of Psychiatry,
Vol. 148,
Issue. 6,
p.
744.
Manchanda, R.
Saupe, R.
and
Hirsch, S. R.
1986.
Comparison between the Brief Psychiatric Rating Scale and the Manchester Scale for the rating of schizophrenic symptoms.
Acta Psychiatrica Scandinavica,
Vol. 74,
Issue. 6,
p.
563.
Manchanda, Rahul
1987.
Dextro-propranolol and depressive symptoms in a schizophrenic population.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 11,
Issue. 5,
p.
625.
Das, Indrajit
De Belleroche, Jacqueline
and
Hirsch, Steven
1988.
Stimulation of inositol phosphate production by propranolol in human neutrophils.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 12,
Issue. 5,
p.
721.
Gureje, O.
1988.
Neurological soft signs in Nigerian schizophrenics: a controlled study.
Acta Psychiatrica Scandinavica,
Vol. 78,
Issue. 4,
p.
505.
1989.
Current Perspectives Pharmacotherapy of Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 34,
Issue. 5,
p.
457.
Remington, G.
1989.
Pharmacotherapy of Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 34,
Issue. 3,
p.
211.
Hirsch, S. R.
and
Barnes, T. R. E.
1990.
Methodology of the Evaluation of Psychotropic Drugs.
p.
26.
Jackson, H. J.
Burgess, P. M.
Minas, I. H.
and
Joshua, S. D.
1990.
Psychometric properties of the Manchester Scale.
Acta Psychiatrica Scandinavica,
Vol. 81,
Issue. 2,
p.
108.
Gelenberg, Alan J.
1990.
Handbook of Outpatient Treatment of Adults.
p.
41.
Fritze, J.
1992.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
59.
Borchard, U.
Gastpar, M.
and
Rimpel, J.
1992.
Neuro-Psychopharmaka.
p.
99.
Wykes, T.
1992.
Schizophrenia.
p.
221.
Awad, A. George
1993.
Methodological and Design Issues in Clinical Trials of New Neuroleptics: an Overview.
British Journal of Psychiatry,
Vol. 163,
Issue. S22,
p.
51.
Delini-Stula, A
and
Berdah-Tordjman, D
1994.
Placebo controlled studies in acute schizophrenia – an issue of concern.
European Psychiatry,
Vol. 9,
Issue. 4,
p.
165.
Deakin, J.F.W.
Simpson, M.D.C.
Slater, P.
and
Hellewell, J.S.E.
1997.
Familial and developmental abnormalities of frontal lobe function and neurochemistry in schizophrenia.
Journal of Psychopharmacology,
Vol. 11,
Issue. 2,
p.
133.
Shek, Elena
Bardhan, Sabyasachi
Cheine, Maxim V
Ahonen, Juha
and
Wahlbeck, Kristian
2001.
Beta-blocker supplementation of standard drug treatment for schizophrenia.
Cochrane Database of Systematic Reviews,
Corlett, Philip R
Honey, Garry D
Krystal, John H
and
Fletcher, Paul C
2011.
Glutamatergic Model Psychoses: Prediction Error, Learning, and Inference.
Neuropsychopharmacology,
Vol. 36,
Issue. 1,
p.
294.
Stevens, Jonathan R.
Fava, Maurizio
Rosenbaum, Jerrold F.
and
Alpert, Jonathan E.
2011.
Massachusetts General Hospital Handbook of General Hospital Psychiatry.
p.
441.
Fitzgerald, Paul J.
2014.
Is elevated norepinephrine an etiological factor in some cases of schizophrenia?.
Psychiatry Research,
Vol. 215,
Issue. 3,
p.
497.
eLetters
No eLetters have been published for this article.